KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹169 Cr | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr |
What is the latest Total Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹169 Cr |
| Mar2024 | ₹178 Cr |
| Mar2023 | ₹175 Cr |
| Mar2022 | ₹190 Cr |
| Mar2021 | ₹159 Cr |
How is Total Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹169 Cr | -5.13 | |
| Mar2024 | ₹178 Cr | 1.82 | |
| Mar2023 | ₹175 Cr | -7.81 | |
| Mar2022 | ₹190 Cr | 19.21 | |
| Mar2021 | ₹159 Cr | - | |
Compare Total Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹144.2 Cr | 3.7% | -4.7% | -14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,170.0 Cr | -1.6% | 4.6% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,038.0 Cr | -2.5% | -6% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,357.0 Cr | 1.2% | -1.4% | 11.8% | Stock Analytics | |
| CIPLA | ₹120,414.0 Cr | -1.2% | -1.5% | -0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,015.0 Cr | -2.7% | 4% | 2.2% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 3.7% |
-4.7% |
-14.5% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses